Wealthcare Advisory Partners LLC Aerie Pharmaceuticals Inc Transaction History

Wealthcare Advisory Partners LLC

  • $3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$15.16 - $18.97 $1,895 - $2,371
-125 Closed
0 $0
Q1 2021

Apr 30, 2021
BUY
$13.12 - $20.9 $1,640 - $2,612
125 New
125 $2,000
Q2 2020

Jul 29, 2020
SELL
$12.0 - $16.13 $1,500 - $2,016
-125 Closed
0 $0
Q4 2019

Jan 29, 2020
BUY
$17.72 - $25.1 $2,215 - $3,137
125 New
125 $3,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email